Mersana Therapeutics
MRSN
MRSN
128 hedge funds and large institutions have $149M invested in Mersana Therapeutics in 2024 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 33 increasing their positions, 40 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
18% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 40
32% less capital invested
Capital invested by funds: $219M → $149M (-$70.3M)
82% less call options, than puts
Call options by funds: $356K | Put options by funds: $2.02M
Holders
128
Holding in Top 10
1
Calls
$356K
Puts
$2.02M
Top Buyers
| 1 | +$6.08M | |
| 2 | +$1.03M | |
| 3 | +$987K | |
| 4 |
BlackRock
New York
|
+$834K |
| 5 |
Millennium Management
New York
|
+$767K |
Top Sellers
| 1 | -$11.5M | |
| 2 | -$5.71M | |
| 3 | -$3M | |
| 4 |
Goldman Sachs
New York
|
-$1.65M |
| 5 |
VA
VR Adviser
New York
|
-$1.53M |